pCPA File Number: 21444
Under consideration for negotiation
Isatuximab in combination with pomalidomide and dexamethasone, for the treatment of patients with relapsed and refractory multiple myeloma who have received at least two prior therapies including lenalidomide and a proteasome inhibitor.
CADTH Project Number:
pCPA Engagement Letter Issued:
Negotiation Process Concluded: